Psychemedics

Psychemedics Net Debt per Share

The Net Debt per Share of Psychemedics (PMDI) as of Nov 5, 2026 is 0.05 USD. In the previous year, Net Debt per Share was 0.10 USD — a change of -49.08% (lower).

Net Debt per Share

0.05USD

YoY

-49.08%

Last updated:

Net Debt per Share of Psychemedics is 2022 0.05 USD. Net Debt per Share of Psychemedics was 2021 0.10 USD. It decreases by -49.08% lower compared to the previous year.

The Psychemedics Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2015
0.52 USD
Jan 1, 2016
-0.09 USD
Jan 1, 2017
-0.78 USD
Jan 1, 2018
-1.04 USD
Jan 1, 2019
-0.76 USD
Jan 1, 2020
0.56 USD
Jan 1, 2021
0.10 USD
Jan 1, 2022
0.05 USD
The Psychemedics Net Debt per Share history
YEARNet Debt per ShareYoY
0.05USD-49.08%
0.10USD-82.61%
0.56USD-174.06%
-0.76USD-26.66%
-1.04USD+32.36%
-0.78USD+755.36%
-0.09USD-117.50%
0.52USD+21.21%
0.43USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psychemedics Stock analysis

What does Psychemedics do? Psychemedics Corp provides drug testing services analyzing hair samples for drug presence, offering historical usage patterns and approximate drug intake levels. The company charges customers a per-unit fee for each tested sample, including training for sample collection and storage of positive results. Their primary service targets clients needing drug testing solutions, particularly in sectors requiring regular monitoring of substance use. The firm's technology focuses on hair analysis to deliver detailed insights into drug consumption over time. Psychemedics Corp's revenue model is based on per-unit testing fees, with services including sample collection training and storage of positive samples. Customers pay for each sample tested, leveraging the company's hair analysis technology to monitor drug use patterns. The business operates within the drug testing services segment, serving clients who require reliable and historical data on substance abuse. The company's drug testing services are designed for customers seeking detailed historical data on drug use, with results indicating both the amount ingested and usage patterns over time. Psychemedics Corp generates income through fixed fees per sample tested, covering the full service including sample collection training and positive sample storage. Their focus remains on delivering accurate, long-term drug usage insights through hair analysis. Psychemedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psychemedics stock

Net Debt per Share of Psychemedics is 0.05 USD in 2022.

Net Debt per Share of Psychemedics changed from 0.10 USD to 0.05 USD, representing a -49.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Psychemedics since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Psychemedics

All Key Metrics — Psychemedics